Pluri Inc. (PLUR)
$1.47+$0.00 (+0.00%) Today
Pluri Inc is a biotechnology company engaged in the research, development, and manufacturing of cell-based products, as well as the commercialization of cell therapeutics and related technologies aimed at delivering solutions across a range of industries, including regenerative medicine, immunotherapy, food tech, CDMO, and AgTech. The company uses its 3D cell expansion technology platform to develop placenta-based cell therapy product candidates (PLX-PAD and PLX-R18) for the treatment of inflammatory, muscle injuries, and hematologic conditions. In addition, it offers CDMO services through PluriCDMO, has launched a novel immunotherapy platform, and is engaged in developing cultivated, cell-cultured coffee and meat.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 3 | 212,210 | |
| Other acquisition / disposition | 1 | 625,000 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
16 Form 4 filings on record, the earliest from Jul 1, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Doron Shorrer - Director | Grant or award | Common Stock | 31,569 | $0.00 | - | |
| Alexandre Weinstein Manieu - Director | Grant or award | Common Shares | 180,000 | $0.00 | - | |
| Alexandre Weinstein Manieu - Director | Grant or award | Common Stock | 641 | $0.00 | - | |
| Alexandre Weinstein Manieu - Director | Other | Warrants | 625,000 | $0.00 | - | |
| Alexandre Weinstein Manieu - Director | Grant or award | Common Stock | 312,500 | $2.00 | $625K | |
| Alexandre Weinstein Manieu - Director | Grant or award | Common Stock | 312,500 | $2.00 | $625K | |
| Alexandre Weinstein Manieu - Director | Grant or award | Warrants | 312,500 | $2.00 | $625K | |
| Alexandre Weinstein Manieu - Director | Grant or award | Warrants | 312,500 | $2.00 | $625K | |
| Alexandre Weinstein Manieu - Director | Grant or award | Common Stock | 625,000 | $2.00 | $1.25M | |
| Alexandre Weinstein Manieu - Director | Grant or award | Warrants | 625,000 | $2.00 | $1.25M | |
| Alexandre Weinstein Manieu - Director | Grant or award | Common Stock | 519 | $0.00 | - | |
| Eitan Ajchenbaum - Director | Grant or award | Common Stock | 668 | $0.00 | - | |
 Yaky Yanay - Officer | Grant or award | Common Stock | 6,588 | $0.00 | - | |
| Rami Avraham Levi - Director | Grant or award | Common Stock | 653 | $0.00 | - | |
| Liat Zalts - Officer | Grant or award | Common Stock | 3,660 | $0.00 | - | |
| Maital Shemesh-Rasmussen - Director | Grant or award | Common Stock | 699 | $0.00 | - | |
| Zami Aberman - Director | Grant or award | Common Stock | 346 | $0.00 | - | |
| Alexandre Weinstein Manieu - Director | Option exercise | Pre-Funded Warrants to purchase Common Shares | 1,002,169 | $0.00 | - | |
| Alexandre Weinstein Manieu - Director | Grant or award | Common Warrants | 84,599 | $0.00 | - | |
| Alexandre Weinstein Manieu - Director | Grant or award | Common Stock | 10,250 | $0.00 | - | |
| Alexandre Weinstein Manieu - Director | Option exercise | Common Stock | 1,002,169 | $0.00 | $100 | |
| Alexandre Weinstein Manieu - Director | Open-market purchase | Common Stock | 452,702 | $4.61 | $2.09M | |
| Eitan Ajchenbaum - Director | Grant or award | Common Stock | 11,685 | $0.00 | - | |
| Yaky Yanay - Officer | Grant or award | Common Stock | 39,050 | $0.00 | - | |
| Yaky Yanay - Officer | Grant or award | Stock Option | 39,050 | $0.00 | - | |
| Alexandre Weinstein Manieu - Director | Open-market purchase | Common Stock | 523,437 | $4.61 | $2.41M | |
| Alexandre Weinstein Manieu - Director | Open-market purchase | Common Stock | 452,702 | $4.61 | $2.09M | |
| Alexandre Weinstein Manieu - Director | Other | Common Stock | 976,139 | - | - | |
| Alexandre Weinstein Manieu - Director | Other | Pre-Funded Warrants to purchase Common Shares | 976,139 | - | - |
Pluri Inc. (PLUR) had 3 insider filings in the last 90 days, with the most recent on 2026-08-24. The full record for PLUR runs to 16 Form 4 filings, the earliest from 2025-07-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of PLUR were filed in the last 90 days. 3 purchases are on record for this company.
No insider sales of PLUR were filed in the last 90 days.
This page tracks PLUR Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add PLUR to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
